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Bone marrow-derived mesenchymal stem cells (MSCs) are pluripotent stem cells 
that show a vital potential in the clinical application for cell transplantation. In 
the present paper, proteomic techniques were used to approach the protein ]profiles 
associated with porcine bone marrow MSCs and investigate the regulation of MSC 
proteins on the effect of 5-azacytidine (5-aza). Over 1,700 protein species were 
separated from MSCs according to gel analysis. Compared with the expression 
profiling of control MSCs, there were 11 protein spots up-regulated and 26 down- 
regulated in the protein pattern of 5-aza-treated cells. A total of 21 proteiins were 
successfully identified by MALDI-TOF-MS analysis, among which some interesting 
proteins, such as alpha B-crystallin, annexin A2, and stathmin 1, had been reported 
to involve in cell proliferation and differentiation through different signaling path- 
ways. Our data should be useful for the future study of MSC differentiation and 
apoptosis. 
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Introduction 
The interest in the research of bone marrow mes- 
enchymal stem cells (MSCs) has recently been in- 
creased by reports suggesting that MSCs seem to 
be pluripotent ( 1 , 2 )  and may play a future thera- 
peutic role in cellular replacement strategies for clin- 
ical applications. It is reported that MSCs could 
differentiate into cardiomyocytes after exposure to 
5-azacytidine (5-aza) ( 3 ) ,  and the MSC-derived car- 
diomyocytes could provide a useful and powerful tool 
for cardiomyocyte transplantation (4  ). Researches 
have shown that MSCs are capable of the stable car- 
diac engraftment and site-specific differentiation in 
myocardial scar tissues in the animal model of in- 
farction (5,6). Recent study of mononuclear bone 
marrow cells demonstrate that the selectively intra- 
coronary transplantation of autologous bone marrow 
cells is safe and seems to  be effective for acute my- 
ocardial infarction patients under clinical conditions 
(7). 
As an animal model, pig is often used in experi- 
ments because of several distinct advantages (8). 
Some reports have been published on the porcine 
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MSCs, including their isolation ( 9 ) ,  cardiac differenti- 
ation (10-12), induced osteoclastogenesis (13),  and 
pluripoteiicy (14 ). Despite this promising progress, 
the detailed molecular events that occur during the 
MSC differentiation induced by 5-aza still need to be 
fully understood, and some researchers have proposed 
a different view on this issue ( 1 5 ) .  
With the development of mass spectrometry (MS) 
technology, proteomics has been widely used for the 
analysis of cell proliferation and differentiation un- 
der different conditions (16,17). It has a potential 
for the definition of stem cell populations (18 )  and 
differentiation (19-21 ). However, compared with the 
gene study of MSCs (22-25), only a few proteomic 
reports on MSCs can be found in literature (26 ,27) .  
In the present study, we analyzed the protein pat- 
tern of porcine bone marrow MSCs by using two- 
dimensional (2D) gel electrophoresis to investigate the 
changes (increase or decrease) of protein expression on 
the effect of 5-aza. Protein spots at different expres- 
sion levels were examined by MS, and 21 proteins were 
successfully identified by peptide mass fingerprinting 
(PMF) with MS analysis. The results suggest that 
the molecular mechanisms of MSCs treated by 5-aza 
in vitro might be associated with thew functional pro- 
teins. 
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Results and Discussion 
Isolation of MSCs and treatment by 5- 
aza 
The future use of adult MSCs for human therapies 
depends on the establishment of preclinical studies 
with other mammals such as rat and pig. The iso- 
lation of MSCs from porcine bone marrow was suc- 
cessfully completed (9). Two major types of cells, 
MSCs and hematopoietic stem cells (HSCs), were pre- 
pared from bone marrow. MSCs were spindle-shaped, 
attached to the culture dish, and proliferated in the 
culture medium. HSCs were rowed, not attached to 
the culture dish, and were removed with the culture 
medium change. According to the previous report 
(5), MSCs were cultured at the Dulbecco’s modified 
Eagles’ medium (DMEM), which was changed twice 
every week. 
Protein separation by 2D gel elec- 
trophoresis 
For the purpose of initially scanning the changes in 
the protein levels of MSCs treated by 5-aza, we used 
IPG strips with a wide range of linear IPG (pH 3-10) 
in the first dimension. In the wide-range 2D maps, 
there was a loss of resolution in the region pH 5-8. 
Most probably the fact is due to  that the p1 values 
of many proteins occur in this range. Therefore, we 
also performed electrophoresis on pH 5-8 to achieve 
a better protein separation. These narrow pH gels al- 
lowed a higher resolution and more protein spots in 
the relative pH zones. Figure 1 shows the analytical 
silver-stained 2D maps of MSCs using different pH- 
range IPG strips. 
Comparison of protein patterns be- 
tween control and 5-aza-treated MSCs 
To investigate the effect of 5-aza on the expres- 
sion of proteins, we compared the protein expres- 
sion profiles between control and 5-aza-treated MSCs 
(Figure 2). Three analytical gels were run for each 
sample. Proteins were considered to be significantly 
up- or down-regulated when the corresponding spot 
volumes showed an increase (>two folds) or decrease 
(<50%). According to the analysis, about 1,700 pro- 
tein spots were detected from the silver-stained gels 
of control and treated MSCs. Compared with the 
profiling of control MSCs, there were 11 protein spots 
up-regulated (>two folds) and 26 down-regulated in 
the protein pattern of treated cells according to the 
density of protein spots. These differently expressed 
proteins that can be detected in CBB R-250 stained 
gels were chosen for further MS analysis. 
Protein identification 
Based on the comparison of protein profiles of con- 
trol and treated MSCs, we chose the protein spots 
differently expressed for the protein identification 
by MS. The protein spots in different sets of the 
gels were identified by the matrix-assisted laser des- 
orption/ionization time-of-flight mass spectrometry 
(MALDI-TOF-MS) analysis on the basis of peptide 
mass matching with the theoretical peptide masses in 
tryptic digests of all known proteins from the NCBI 
nonredundant (NCBInr) database and the Swiss-Prot 
database. Table 1 lists the identified proteins in our 
study. 
Functional analysis of the identified 
proteins 
After protein identification, we analyzed the informa- 
tion of these identified proteins from the NCBInr and 
Swiss-Prot databases. Some interesting proteins, such 
as HSP27 (a heat shock protein), alpha B-crystallin 
(an HSP), annexin A2 (a calcium-binding protein), 
and stathmin 1 (a structural protein), were regulated 
when MSCs were treated with 5-aza. 
HSP27 and alpha B-crystallin are a group of 
stress-related proteins that are synthesized by cells 
in response to heat and other environmental stress. 
Their expression in cells may have important physio- 
logical and pathological implications such as protec- 
tion, cell proliferation, migration and differentiation, 
and disease prognosis. Increasing evidence suggests 
that the HSP family of chaperones may play a role in 
the formation and function of cytoskeleton (28). The 
small HSP alpha B-crystallin is a molecular chaperone 
whose function is to  stabilize the proteins damaged 
by inflammatory stress. In our experiment, alpha 
B-crystallin (P02, gi175063982) showed up-regulation 
(-4 folds). HSP27 is part of a signaling pathway regu- 
lating the dynamics of actin filaments (29). Interest- 
ingly, HSP27 has been shown to be essential for the 
differentiation of mouse embryonic stem cells (30) .  
The different expression of HSP27 (P06, P11, and 
P19, gi155926209) showed that it is also involved in 
the treatment process of MSCs. 
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Fig. 1 Effect of IPG strips with different pH range on the protein expression of MSCs. The protein lysates (100 pg) 
were subjected to 2D gel electrophoresis, followed by silver staining and image analysis. Results were quantified from 
three sets of 2D gel electrophoresis. IEF (pH 3-10 and pH 5-8, linear gradient) is in the horizontal direction. SDS-PAGE 
(12% gel) is in the vertical direction. 
Fig. 2 The 2D profiles of control and treated MSCs. Upward arrows indicate up-regulation, and downward arrows 
indicate down-regulation. The spots of interest were excised from the gels and digested with trypsin. The extracted 
peptides were subjected to MALDI-TOF-MS, and the spectra of peptides were used for protein identification. The 
marked spots were successfully identified and the information of proteins was listed in Table 1. 
About two-fold down-regulation expression of an- 
nexin A2 (P20, gi154020966) was found in our study. 
Annexins are phospholipid-binding proteins that may 
cross-link plasma membrane phospholipids, actins, 
and cytoskeletons to regulate proliferation, exocyto- 
sis, and membrane fusion. The annexin A2 gene is 
a growth-regulated gene in mammalian cells, and the 
annexin A2 protein links the plasma membrane to cy- 
toskeleton in a calcium-dependent manner. Gilmore 
e t  a1 ( 3 2 )  reported that annexin A2 is an important 
player in the cellular differentiation of myeloid cell 
lines. 
Peroxiredoxins (Prdxs) are a family of antioxidant 
proteins that reduce peroxide levels by using reduc- 
ing agents such as thioredoxin. In addition to their 
antioxidant activity, Prdxs have been implicated in a 
number of cellular functions such as cell proliferation 
and differentiation (32 ) ,  enhancement of the natural 
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Table 1 Proteins Identified by MALDI-TOF-MS 
No. Protein/Gene name Accession MW (kDa) Score Matched/ Seqence Regulation 
No. /PI all peptides coverage 
PO1 
PO2 
PO3 
PO4 
PO5 
PO6 
PO7 
PO8 
PO9 
P10 
P11 
P12 
P13 
P14 
P15 
P16 
P17 
P18 
P19 
P20 
P21 
Phosphopyruvate hydratase 
(Fragment) 
Alpha B-crystallin (Cryab) 
Peptidyl-prolyl isomerase A 
Moesin (Msn) 
( P P 4  
Cardiac alpha tropomyosin 
Heat shock 27 kDa protein 1 
P hosphopyruvate hydr at ase 
(Enolase) 
Beta-catenin (Ctnnbl) 
(Tpml) 
(HSPbl) 
Peroxiredoxin 2 (Prdx2) 
MHC class I antigen (Sla-3) 
Heat shock 27 kDa protein 1 
Superoxide dismutase 1 
(Sodl) 
Guanosine diphosphate dis- 
sociation inhibitor 2 (Gdi2) 
Cytoskeletal beta actin 
(Actb) 
Guanosine diphosphate dis- 
sociation inhibitor 2 (Gdi2) 
Peroxiredoxin 6 (Prdx6) 
(HSPbl) 
Aldose reductase (Akrlbl) 
Esterase D (Esd) 
Heat shock 27 kDa protein 1 
Annexin A2 (Anxa2) 
(HSPbl) 
Stathmin 1 (Stmnl) 
Q29568 
gi175063982, 
Q7M2W6 
gi 15 1702768, 
P62936 
gi1127236, 
P26042 
giJ1927, 
P42639 
gi155926209 
Q29568 
gi147523792, 
Q8WNW4 
giJ1717797, 
P52552 
gi133468760, 
Q7YNZ2 
gi155926209 
gill5082144, 
Q95ME5 
gi/ 75043802, 
Q6Q7J2 
gi145269029, 
Q6QAQ1 
gi 148675953, 
Q6Q7J2 
gi147523870, 
Q9TSX9 
gil48374071, 
P80276 
gil7288152, 
Q9GM98 
gi(55926209 
gi154020966, 
Q5Y2C7 
gi157528035, 
Q6DUB7 
16.08/4.6 
20.1316.8 
17.9618.4 
67.6616.3 
32.7214.7 
22.9816.2 
16.0814.6 
85.5115.5 
14.1814.7 
43.6815.4 
22.9416.2 
15.25/6.0 
50.2716.3 
44.7915.5 
50.2716.3 
25.0415.7 
35.8715.9 
31.4116.8 
22.9816.2 
38.5416.5 
17.2915.8 
119 
116 
104 
77 
138 
82 
63 
83 
129 
71 
122 
87 
66 
67 
54 
151 
183 
62 
153 
85 
84 
11/42 
4/19 
12/42 
8/28 
24/77 
9/40 
8/31 
5/10 
517 
4/28 
5/31 
8/28 
4/14 
7/23 
6/21 
8/11 
10112 
4/14 
13/34 
5/38 
6/11 
71% 
21% 
57% 
11% 
59% 
35% 
51% 
7% 
36% 
10% 
22% 
44% 
8% 
19% 
22% 
40% 
38% 
13% 
42% 
16% 
36% 
High 
expression 
4.14 
2.26 
2.07 
1.83 
1.77 
1.59 
1.48 
1.33 
1.19 
1.11 
1.10 
1.09 
1.08 
1.06 
0.96 
0.95 
0.84 
0.80 
0.60 
0.53 
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killer cell activity, protection of radical-sensitive pro- 
teins, metabolism, and intracellular signaling (33 ) .  
Our data showed that two isoforms were found in 
the control and treated MSCs. However, Prdx2 (PO9, 
gill717797) and Prdx6 (P16, gi147523870) showed in- 
versely regulation between the proliferating and treat- 
ing stages, which may contribute to the using of 
different reducing agents. Therefore, they may be 
involved in different signaling pathways. 
Beta-catenin is a multifunctional protein that 
is known to participate in two well-defined cellu- 
lar processes, cell-cell adhesion and Wnt-stimulated 
transcriptional activation (34, 35). Mbalaviele et  
al (36) demonstrated that beta-catenin, in synergy 
with BMP-2, promotes the MSC commitment to the 
oteoblast pathway, inhibits adipogenic differentiation, 
and induces bone formation in wivo. Furthermore, 
the Wntlbeta-catenin pathway regulates the cardiac 
valve formation (37). Nakamura e t  al (38) tested the 
involvement of Wnt and beta-catenin in mammalian 
cardiac myogenesis by using a pluripotent mouse cell 
line (P19CL6) that recapitulates the early steps for 
cardiac specification. Their findings suggested that 
Wntlbeta-catenin signaling is activated at the incep- 
tion of mammalian cardiac myogenesis and is indis- 
pensable for cardiac differentiation, at least in this 
pluripotent model system. From our data, the beta- 
catenin (P08, $3147523792) showed up-regulation by 
the 5-aza treatment; it may be involved in the cell 
process through the Wnt signaling pathway. 
Three closely related proteins, namely ezrin, 
radixin, and moesin, which compose the ERM family, 
are thought to work as cross-linkers between plasma 
membranes and actin-based cytoskeletons. In our 
study, the moesin (P04, gi1127236) expressed up- 
regulation by the 5-aza treatment. Real-time PCR 
confirmed a significant reduction of moesin gene ex- 
pression following the dexamethasone treatment. The 
decrease of expression for this protein, which involves 
in the cytoskeletal organization, could explain the 
effects of the dexamethasone treatment on bone mar- 
row stromal cell differentiation (39). 
Stathmin 1 (P21, gi157528035) showed down- 
regulation by the 5-aza treatment. It is a ubiquitous 
cytosolic protein that has been independently studied 
in various cellular systems under different names, in- 
cluding Oncoprotein 18, metablastin phosphoprotein 
19, and LAP18. Stathmin 1 is proposed to act as a 
relay for a diverse array of cell signaling pathways, 
which influences cell growth and differentiation (40- 
43) .  The function of stathmin 1 during the MSC 
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differentiation needs to be investigated in further re- 
search. 
According to  the previous reports, these func- 
tional proteins may play an important role in the 
cell process of MSCs induced by s-aza, and they 
should be highlighted during the MSC proliferation 
and differentiation research. 
Conclusion 
In conclusion, this study describes for the first time 
a proteomics approach employed to understand the 
biochemical processes related to  porcine bone morrow 
MSCs treated by 5-aza. The expression level of pro- 
teins involved in cell proliferation and differentiation 
as well as cell defense was found to  change when MSCs 
were treated by 5-aza. Our data should be useful for 
the future study of MSC differentiation and apopto- 
sis. 
Materials and Methods 
Cell culture 
The porcine sample was anesthetized by an injection 
of sodium pentobarbital (20 mg/kg). Under anes- 
thesia, thighbone was excised by a syringe contain- 
ing heparin with an 18-gauge needle. Mononuclear 
bone marrow cells were obtained by centrifugation. 
Cells were cultured in DMEM (Gibco BRL, Rockville, 
USA) supplemented with 10% fetal bovine serum 
(Hyclone, Logan, USA), penicillin, and streptomycin 
(Sigma, St. Louis, USA) at 37°C humidified atmo- 
sphere with 5% COz for three days before the first 
medium change, and then the medium was changed 
twice a week. At 90% confluence, the cells were 
trypsinized with 0.25% trypsin-EDTA and were pas- 
saged to flask at 1:3 ratio. 
For the 5-aza treatment, the MSCs at passage 2 
were cultured for 72 h, incubated with the medium 
containing 10 pM 5-aza for 24 h, and then cultured 
with DMEM without 5-aza. About lo6 MSCs were 
harvested by gently trypsinization after incubation for 
three weeks, and the harvested cells were washed by 
cold PBS solution and centrifuged at 800 g for 10 min 
at 4°C for more than three times. The pipettes were 
stored at -80°C before protein lysis. Triplicate con- 
trol and treated MSCs were cultured for the future 
protein preparation. 
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Sample preparation 
The harvested cells were washed by cold PBS and the 
cellular pellets were dissolved in a lysis buffer con- 
taining 8 M urea (Promega, Madison, USA), 4% w/v 
CHAPS (Promega), 100 mM DTT (Promega), 0.5% 
ampholyte (Bio-Rad Laboratories, Hercules, USA), 
and 1 mM PMSF (Promega), and then sonicated at 
4°C for 2 min. After that, the DNase and RNase 
(Roche, Basel, Switzerland) solution was added and 
laid at 4°C for 15 min. The sample was then cen- 
trifuged at 14,000 g for 30 min at 4°C to remove any 
insoluble cell debris. The total protein concentration 
was determined using the Bradford method and the 
remained protein solution was stored at -80°C for 
further proteomic analysis. 
2D gel electrophoresis 
For the first dimension, 350 pL of each sample (100 
pg and 600 pg of proteins for analytic and preparative 
gels, respectively) was subjected to isoelectric focus- 
ing (IEF) on an IPG strip (pH 3-10 or pH 5-8, 17 cm, 
linear gradient, Bio-Rad). The amount of proteins 
applied in the samples from the different treatment 
groups (control and treated MSCs) was the same in 
each experimental repeat, allowing comparisons be- 
tween the different groups. IPG Ready Strips were 
actively rehydrated at 50 V for 15 h to enhance pro- 
tein uptake. IEF was carried out on a Protean IEF 
Cell (Bio-Rad) at 20°C with a maximum current set- 
ting of 50 pA per gel. Focusing was performed using 
a four-phase program in which the first phase was at 
250 V for 30 min, the second at 1 kV for 1 h, the 
third at 10 kV for 5 h at a linear ramping mode, and 
the final phase at 10 kV for 6 h. After focusing, the 
strips were either stored at -80°C or used directly for 
2D gel electrophoresis. Prior to the 2D SDS-PAGE, 
IPG strips were incubated for 10 min in the equili- 
bration buffer (50 mM Tris-HC1, pH 8.8, 6 M urea, 
30% v/v glycerol, 2% w/v SDS) supplemented with 
10 mg/mL DTT (Promega), followed by a 10-minute 
incubation in the equilibration buffer supplemented 
with 25 mg/mL iodoacetamide (Bio-Rad), then rinsed 
once with the SDS-PAGE buffer (25 mM Tris, 192 
mM glycine, pH 8.3, 0.1% SDS). The strips were then 
transferred on the 2D SDS-PAGE gel and sealed in 
place with 0.5% low melting point agarose (Promega). 
Proteins were resolved by 12% SDS-PAGE using a 
Protean I1 XL system (Bio-Rad). Electrophoresis was 
carried out at 10 mA per gel for 30 min, followed by 
Geno. Prot. Bioinfo. 
30 mA per gel until the bromophenol blue front 
reached the bottom of the gel, and the temperature 
of the electrophoresis system was kept at the range of 
4" C-5"C. 
Detection of proteins and image analy- 
sis 
Analytical gels were silver-stained according to the 
protocol for compatibility with subsequent analysis of 
proteins by MS. Gels were fixed for 15 min in 40% v/v 
methanol, 10% v/v acetic acid, followed for another 15 
min after changing fresh fixation solution.. Gels were 
sensitized for 30 min in 0.02% w/v sodium thiosul- 
fate, followed by three times of 5-minute washes with 
Milli-Q water, and then incubated in chilled (4°C) 
0.25% w/v silver nitrate for 20 min, followed again 
by three times of 1-minute washes. Proteins were 
then visualized by several times of washes with the 
developing solution (2.5% sodium carbonate, 0.04% 
formaldehyde) until a desired level of staining was 
achieved, after which the development was stopped 
with 1.46% EDTA solution. 
Preparative gels were incubated for 1 h in 50% v/v 
methanol/lO% v/v acetic acid, 0.1% w/v CBB R-250, 
and the excess dye was removed with several changes 
of 20% v/v methanol, 10% v/v acetic acid. Gels were 
digitized at a resolution of 300 dpi using a Power- 
Look 2100XL scanner system (UMAX Technologies, 
Inc., Dallas, USA). Protein spots were then located, 
quantified, and matched to the spots on comparative 
gels using PDQuest 7.1 software (Bio-Rad). Analyti- 
cal gels were analyzed to investigate the expression of 
proteins between control and treated MSCs. The cor- 
responding spots in the preparative gels were matched 
with the spots of interest in analytical gels by the soft- 
ware. 
In-gel digestion and protein iden- 
tif icat ion 
From the 2D gel analysis of control and treated sam- 
ples, differentially expressed proteins were selected for 
the MS identification. These spots were manually 
excised from 2D gels, sliced into small pieces, and 
then destained three times with 25 mM NH4HC03 
buffer (pH 8.0) in 50% v/v acetonitrile (ACN) for 
15 min. The gel pieces were dehydrated in ACN 
for 5 min and then dried for 20 min in a vacuum 
centrifuge. The dried gel volume was evaluated and 
three volumes of trypsin (12.5 ng/pL in 25 mM 
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NH4HC03) were added. The digestion was performed 
at 37°C overnight. The peptide fragments were ex- 
tracted twice with 50 pL of 50% v/v ACN/O.l% v/v 
trifluoroacetic acid (TFA, Sigma). After removal of 
ACN by centrifugation in a vacuum centrifuge, the 
peptides were mixed with a!-cyano-4-hydroxycinnamic 
acid (CHCA, 0.5 pL of 10 mg/mL) and then subjected 
to  a gold-plated sample holder. The samples were 
introduced into the mass spectrometer after drying. 
Protein samples digested by trypsin were analyzed us- 
ing a MALDI-TOF-MS instrument (Bruker Autoflex, 
Billerica, USA). The spectra were obtained in the 
reflection mode by summing 200 laser shots with the 
ion source 1 of 19 kV, ion source 2 of 16.27 kV, 100 
ns delay, and the low mass gate at m/z 600. Pep- 
tide matching was carried out against the NCBInr and 
Swiss-Prot databases using the Mascot tool. The pa- 
rameters were set to  allow one possible missed cleav- 
age for trypsin digestion with a peptide mass tolerance 
of 100 ppm. For an  identity assignment, the minimum 
requirement number was four matching peptides. The 
considered modifications included carbamidomethy- 
lation of cysteine and oxidation of methionine. 
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